| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/05/2004 | CA2493306A1 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 02/05/2004 | CA2492500A1 Method for enhancing yield of recombinant protein production from plants |
| 02/05/2004 | CA2492447A1 Taci antibodies and uses thereof |
| 02/05/2004 | CA2492333A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/04/2004 | EP1386962A1 Methods and compositions for in vitro synthesis of biological macromolecules in a cell-free system enriched with atp-sulfurylase |
| 02/04/2004 | EP1386932A1 Improved humanized immunoglobulins |
| 02/04/2004 | EP1386930A1 Derivatives of exendin |
| 02/04/2004 | EP1386928A1 A frog skin antibacterial peptide derivative |
| 02/04/2004 | EP1386617A1 Method for the in vitro diagnosis of type II porcine circovirus infection and diagnostic reagents |
| 02/04/2004 | EP1386616A1 Antibordetella vaccine |
| 02/04/2004 | EP1386167A2 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 02/04/2004 | EP1386152A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes |
| 02/04/2004 | EP1385979A2 Method for enhancing the translation and expression of recombinant proteins |
| 02/04/2004 | EP1385977A2 Secreted proteins |
| 02/04/2004 | EP1385968A1 Processes and vectors for amplification or expression of nucleic acid sequences of interest in plants |
| 02/04/2004 | EP1385967A2 Non aggregating fluorescent proteins and methods for using the same |
| 02/04/2004 | EP1385963A2 Polypeptides derived from rna polymerases and use thereof |
| 02/04/2004 | EP1385959A2 Method of producing recombinant antibodies against tumours |
| 02/04/2004 | EP1385958A2 Human tachykinin-related splice variants and compositions thereof |
| 02/04/2004 | EP1385955A2 Cell adhesion proteins |
| 02/04/2004 | EP1385954A2 Proteins associated with cell growth, differentiation, and death |
| 02/04/2004 | EP1385953A2 Proteins and nucleic acids encoding same |
| 02/04/2004 | EP1385950A2 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 02/04/2004 | EP1385946A2 A system for inducible expression in eukaryotic cells |
| 02/04/2004 | EP1385945A1 Novel mutation |
| 02/04/2004 | EP1385943A2 Novel alkaline protease variants and detergents and cleaning agents containing said novel alkaline protease variants |
| 02/04/2004 | EP1385935A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway |
| 02/04/2004 | EP1385885A2 Fragments of the retinoic acid-related orphan receptor (ror) comprising the ligand binding domain (lbd), crystal structure of the lbd of ror-beta and their applications |
| 02/04/2004 | EP1385883A2 Transmembrane proteins |
| 02/04/2004 | EP1385866A2 Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast |
| 02/04/2004 | EP1385864A1 Vascular endothelial growth factor 2 |
| 02/04/2004 | EP1385861A2 Compositions and methods relating to lung specific genes and proteins |
| 02/04/2004 | EP1385555A1 Viral vectors having reduced virulence |
| 02/04/2004 | EP1385545A2 Humanized antibodies |
| 02/04/2004 | EP1385543A1 Human medical treatment by application of immunoglobulin a |
| 02/04/2004 | EP1107799B1 Method for labeling biopolymers using isotopes |
| 02/04/2004 | EP0848755B9 Vegf-related protein |
| 02/04/2004 | EP0789766B1 Chimeric papillomavirus-like particles |
| 02/04/2004 | EP0698094B1 Bmp-11 compositions |
| 02/04/2004 | EP0670848B1 High molecular weight collagen-like protein polymers |
| 02/04/2004 | CN1473166A Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 02/04/2004 | CN1472315A Expression of larynogotracheitis or epiornitic virus gene recombined varicella virus and its use |
| 02/04/2004 | CN1472314A Immunity expression of AIDS virus O and its use |
| 02/04/2004 | CN1472219A Recombined human parathyroid hormone gene, its expression carrier and preparing method of recombined human parathyroid protein |
| 02/04/2004 | CN1471847A Glyptal composition, its preparation and use |
| 02/04/2004 | CN1137383C Human RTN 4B protein and code sequence and its preparation and use |
| 02/04/2004 | CN1137270C Preparation method for producing small molecular weight titanium by using soybean separted protein and its equipment |
| 02/04/2004 | CN1137269C Process for preparing extract of small marine fish |
| 02/04/2004 | CN1137268C Process for preparing bacterial cellulose by glucose oxidation and bacillus fermentation |
| 02/04/2004 | CN1137262C Mutants of Rb and P53 genes and uses thereof |
| 02/04/2004 | CN1137139C Process for producing recombined lymphotoxin derivative |
| 02/04/2004 | CN1136918C Vaccines |
| 02/03/2004 | US6686514 Nucleotide sequences coding enzymatic polypeptide for use in the foods, adhesives, textiles, fertilizers, medicine, cosmetics and papermaking |
| 02/03/2004 | US6686453 Antifucoidan antibody |
| 02/03/2004 | US6686448 Class II cytokine receptor-7 |
| 02/03/2004 | US6686190 Methods for enhancing the production of viral vaccines in cell culture |
| 02/03/2004 | US6686179 Polypeptide for use in the treatment of thrombosis, cancer, inflammation, autoimmune, and bone disorders |
| 02/03/2004 | US6686178 Fusion proteins; interleukins; colony stimulating factors; cellular proliferation/differentiation; culturing bone marrow or peripheral blood cells; natural killer cells |
| 02/03/2004 | US6686177 Delayed onset of action |
| 02/03/2004 | US6686174 Regulating translation of mrna; reduced risk of developing resistance |
| 02/03/2004 | US6686159 Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression |
| 02/03/2004 | US6686153 PRV-1 gene and the use thereof |
| 02/03/2004 | US6685947 Derived from canine distemper virus |
| 02/03/2004 | US6685934 Neurodegenerative diseases. |
| 02/03/2004 | CA2123496C A bacillus promoter derived from a variant of a bacillus licheniforms x-amylase promoter |
| 02/03/2004 | CA2095735C Monoclonal antibodies to hepatitis c virus and method for using same |
| 02/03/2004 | CA2091636C Method for suppressing coloring of human serum albumin |
| 02/03/2004 | CA2025597C Vaccine against lyme disease |
| 01/31/2004 | CA2436507A1 Cell cultures |
| 01/29/2004 | WO2004009838A2 H. Pylori FUCOSYLTRANSFERASES |
| 01/29/2004 | WO2004009832A1 High throughput production of antibodies to genomic-derived proteins |
| 01/29/2004 | WO2004009831A1 Methods of enhancing yields of soluble proteins |
| 01/29/2004 | WO2004009799A2 Ion channel receptor and uses thereof |
| 01/29/2004 | WO2004009793A2 Synthesis of glycoproteins using bacterial gycosyltransferases |
| 01/29/2004 | WO2004009782A2 Methods for generating enhanced antibody-producing cell lines with improved growth characteristics |
| 01/29/2004 | WO2004009775A2 Methods and compositions relating to chimeric nicotinic receptor subunits |
| 01/29/2004 | WO2004009768A2 Viral vectors containing recombination sites |
| 01/29/2004 | WO2004009766A2 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
| 01/29/2004 | WO2004009762A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 01/29/2004 | WO2004009759A2 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 01/29/2004 | WO2004009618A2 Recombinant production of mixtures of antibodies |
| 01/29/2004 | WO2004009021A2 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 01/29/2004 | WO2003066663A3 Peptides for recognition and targeting of glial cell tumors |
| 01/29/2004 | WO2003042367A3 Antibodies that immunospecifically bind to trail receptors |
| 01/29/2004 | WO2003039489A3 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
| 01/29/2004 | WO2003008451A3 Modification of human variable domains |
| 01/29/2004 | WO2002099060A3 Dgks as modifiers of the p53 pathway and methods of use |
| 01/29/2004 | WO2002078631A3 Improved conditionally replicating vectors for inhibiting viral infections |
| 01/29/2004 | WO2002072794A3 Immunoglobulin superfamily proteins |
| 01/29/2004 | US20040019186 Complex of lecithin and sugar; immobilization; washing; liquid removal; recovering |
| 01/29/2004 | US20040019181 Antimicrobial cationic peptides |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040018973 Diagnosis cell proliferation; binding antibody to nucleic acids |
| 01/29/2004 | US20040018969 Genetic engineering; central nervous system disorders |
| 01/29/2004 | US20040018626 Replacement of immunoglobulin in endogenous cells; forming embryos stem cell |
| 01/29/2004 | US20040018618 Genetic engineering; hybrid proteins; gene expression; human gene therapy |
| 01/29/2004 | US20040018596 Process for producing polypeptide having disulfide bond |
| 01/29/2004 | US20040018595 Production of recombinant bmp-2 |
| 01/29/2004 | US20040018594 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 01/29/2004 | US20040018591 Methods and compositions for protein expression and purification |